To gain deeper insights into the biological properties and activities of NF2-EVs within the tumor microenvironment, we conducted a comprehensive proteomic analysis of these tumor-derived extracellular vesicles using mass spectrometry. The gene discussed is NF2; the disease is neoplasm.